Insider Trading & Ownership - Curran Terrie

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Curran Terrie
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
CompanySymbolInsider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2024-11-11
Sale
2024-11-13
6:45 pm
Arcutis Biotherapeutics Inc.ARQTCurran Terrie
Director
8,687$10.85$94,23810,139
(Direct)
View
2024-07-15
Sale
2024-07-17
2:50 pm
Phathom Pharmaceuticals Inc.PHATCurran Terrie
President and Chief Executive
33,848$11.72$396,699381,574
(Indirect
Direct)
View
2024-03-22
Sale
2024-03-26
4:05 pm
Phathom Pharmaceuticals Inc.PHATCurran Terrie
President and Chief Executive
16,851$9.11$153,513414,624
(Indirect
Direct)
View
2023-04-06
Purchase
2023-04-07
3:19 pm
Phathom Pharmaceuticals Inc.PHATCurran Terrie
President and Chief Executive
12,919$7.8199$101,025190,526
(Indirect
Direct)
View
2023-03-01
Sale
2023-03-03
6:59 pm
Phathom Pharmaceuticals Inc.PHATCurran Terrie
President and Chief Executive
1,436$8.5411$12,265177,607
(Indirect
Direct)
View
2023-01-20
Sale
2023-01-20
7:39 pm
Phathom Pharmaceuticals Inc.PHATCurran Terrie
President and Chief Executive
5,821$8.1995$47,729341,543
(Indirect
Direct)
View
2022-11-21
Sale
2022-11-23
4:07 pm
Phathom Pharmaceuticals Inc.PHATCurran Terrie
President and Chief Executive
1,526$9.6$14,65085,956
(Indirect
Direct)
View
2022-05-13
Purchase
2022-05-16
8:45 pm
Phathom Pharmaceuticals Inc.PHATCurran Terrie
President and Chief Executive
20,500$7.4066$151,83565,319
(Indirect
Direct)
View
2021-09-09
Sale
2021-09-13
4:11 pm
Myovant Sciences Ltd.MYOVCurran Terrie
Director
4,850$25.58$124,0635,250
(Direct)
View
2021-09-01
Sale
2021-09-03
4:25 pm
Myovant Sciences Ltd.MYOVCurran Terrie
Director
48,508$25.02$1,213,81457,335
(Direct)
View
2021-03-22
Sale
2021-03-23
7:22 pm
Phathom Pharmaceuticals Inc.PHATCurran Terrie
President and Chief Executive
11,513$43.32$498,751855,687
(Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
CompanySymnbolInsider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2024-06-14
Option Award
2024-06-18
4:52 pm
N/A
2034-06-14
Arcutis Biotherapeutics Inc.ARQTCurran Terrie
Director
37,191$045,878
(Direct)
View
2024-01-18
Option Award
2024-01-22
8:19 pm
N/A
2034-01-17
Phathom Pharmaceuticals Inc.PHATCurran Terrie
President and Chief Executive
475,000$0475,000
(Direct)
View
2023-11-01
Option Award
2023-11-03
4:53 pm
N/A
N/A
Phathom Pharmaceuticals Inc.PHATCurran Terrie
President and Chief Executive
37,500$0430,751
(Direct)
View
2023-07-14
Option Award
2023-07-17
5:00 pm
N/A
N/A
Phathom Pharmaceuticals Inc.PHATCurran Terrie
President and Chief Executive
200,000$0393,251
(Direct)
View
2023-07-14
Disposition
2023-07-17
5:00 pm
N/A
2030-06-30
Phathom Pharmaceuticals Inc.PHATCurran Terrie
President and Chief Executive
400,000$0393,251
(Direct)
View
2023-05-31
Option Award
2023-06-02
7:10 pm
N/A
2033-05-31
Arcutis Biotherapeutics Inc.ARQTCurran Terrie
Director
16,595$020,907
(Direct)
View
2023-03-10
Disposition
2023-03-10
09:27 am
N/A
2026-11-14
Myovant Sciences Ltd.MYOVCurran Terrie
Director
141,622$00
(Direct)
View
2023-01-19
Option Award
2023-01-20
7:39 pm
N/A
2033-01-18
Phathom Pharmaceuticals Inc.PHATCurran Terrie
President and Chief Executive
260,000$0341,543
(Direct)
View
2022-10-26
Option Award
2022-10-28
4:45 pm
N/A
N/A
Myovant Sciences Ltd.MYOVCurran Terrie
Director
9,859$09,859
(Direct)
View
2022-09-01
Option Award
2022-09-02
4:05 pm
N/A
N/A
Phathom Pharmaceuticals Inc.PHATCurran Terrie
President and Chief Executive
7,500$087,482
(Direct)
View
2022-06-01
Option Award
2022-06-03
4:58 pm
N/A
2032-06-01
Arcutis Biotherapeutics Inc.ARQTCurran Terrie
Director
16,108$016,108
(Direct)
View
2022-05-19
Option Award
2022-05-20
5:14 pm
N/A
N/A
Phathom Pharmaceuticals Inc.PHATCurran Terrie
President and Chief Executive
12,000$077,319
(Direct)
View
2022-01-19
Option Award
2022-01-21
6:47 pm
N/A
2032-01-18
Phathom Pharmaceuticals Inc.PHATCurran Terrie
President and Chief Executive
247,500$0250,809
(Direct)
View
2021-11-05
Option Award
2021-11-09
5:40 pm
N/A
2031-11-04
Myovant Sciences Ltd.MYOVCurran Terrie
Director
21,096$021,096
(Direct)
View
2021-09-09
Exercise
2021-09-13
4:11 pm
N/A
2029-08-23
Myovant Sciences Ltd.MYOVCurran Terrie
Director
4,850$05,250
(Direct)
View
2021-09-09
Exercise
2021-09-13
4:11 pm
N/A
N/A
Myovant Sciences Ltd.MYOVCurran Terrie
Director
4,850$7.655,250
(Direct)
View
2021-09-01
Exercise
2021-09-03
4:25 pm
N/A
2029-08-23
Myovant Sciences Ltd.MYOVCurran Terrie
Director
48,508$057,335
(Direct)
View
2021-09-01
Exercise
2021-09-03
4:25 pm
N/A
N/A
Myovant Sciences Ltd.MYOVCurran Terrie
Director
48,508$7.6557,335
(Direct)
View
2021-06-09
Option Award
2021-06-11
4:36 pm
N/A
2031-06-09
Arcutis Biotherapeutics Inc.ARQTCurran Terrie
Director
13,391$013,391
(Direct)
View
2021-03-22
Exercise
2021-03-23
7:22 pm
N/A
N/A
Phathom Pharmaceuticals Inc.PHATCurran Terrie
President and Chief Executive
11,513$6.95855,687
(Direct)
View
2021-03-22
Exercise
2021-03-23
7:22 pm
N/A
2029-08-28
Phathom Pharmaceuticals Inc.PHATCurran Terrie
President and Chief Executive
11,513$0855,687
(Direct)
View
2021-01-28
Option Award
2021-01-29
4:27 pm
N/A
2031-01-27
Phathom Pharmaceuticals Inc.PHATCurran Terrie
President and Chief Executive
225,000$0225,000
(Direct)
View
2020-11-02
Option Award
2020-11-04
4:34 pm
N/A
2030-11-02
Arcutis Biotherapeutics Inc.ARQTCurran Terrie
Director
37,500$037,500
(Direct)
View
2020-09-15
Option Award
2020-09-17
4:16 pm
N/A
2030-09-14
Myovant Sciences Ltd.MYOVCurran Terrie
Director
21,603$021,603
(Direct)
View
2020-07-01
Option Award
2020-07-02
4:44 pm
N/A
2030-06-30
Phathom Pharmaceuticals Inc.PHATCurran Terrie
President and Chief Executive
175,000$0175,000
(Direct)
View